Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Rees

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
European Heart Journal|October 9, 2008
Familial hypercholesterolaemia: underdiagnosed and undertreatedAlan Rees
Current Opinion in Lipidology|September 22, 2007
Atherosclerosis and lipoproteins: vascular cell senescence and atherosclerosisShihong Chen, Alan Rees
Current Opinion in Lipidology|March 14, 2007
Therapy and clinic trialsShihong Chen, Alan Rees
Drug Safety|July 26, 2002
Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?Marc Evans, Alan Rees
Current Opinion in Lipidology|November 6, 2014
Microsomal triglyceride transfer protein inhibition: a novel treatment for lowering plasma cholesterolGautam Das, Alan Rees
Current Opinion in Lipidology|August 2, 2002
The myotoxicity of statinsMarc Evans, Alan Rees
Current Opinion in Lipidology|July 18, 2012
Estimation of cardiovascular risk using 10-year risk metric: time for a rethink?Atul Kalhan, Alan Rees
Current Opinion in Lipidology|March 19, 2011
Statin/ezetimibe combination therapy: emerging evidenceAtul Kalhan, Alan Rees
Current Opinion in Lipidology|July 9, 2014
Novel cardiovascular risk-assessment metrics and absolute risk assessment: future role in clinical practice?Atul Kalhan, Alan Rees
Current Opinion in Lipidology|November 26, 2009
Therapy and clinical trials: glycaemic control and cardiovascular diseaseMahamood Edavalath, Alan Rees
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
European Heart Journal|October 9, 2008
Familial hypercholesterolaemia: underdiagnosed and undertreatedAlan Rees
Current Opinion in Lipidology|September 22, 2007
Atherosclerosis and lipoproteins: vascular cell senescence and atherosclerosisShihong Chen, Alan Rees
Current Opinion in Lipidology|March 14, 2007
Therapy and clinic trialsShihong Chen, Alan Rees
Drug Safety|July 26, 2002
Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?Marc Evans, Alan Rees
Current Opinion in Lipidology|November 6, 2014
Microsomal triglyceride transfer protein inhibition: a novel treatment for lowering plasma cholesterolGautam Das, Alan Rees
Current Opinion in Lipidology|August 2, 2002
The myotoxicity of statinsMarc Evans, Alan Rees
Current Opinion in Lipidology|July 18, 2012
Estimation of cardiovascular risk using 10-year risk metric: time for a rethink?Atul Kalhan, Alan Rees
Current Opinion in Lipidology|March 19, 2011
Statin/ezetimibe combination therapy: emerging evidenceAtul Kalhan, Alan Rees
Current Opinion in Lipidology|July 9, 2014
Novel cardiovascular risk-assessment metrics and absolute risk assessment: future role in clinical practice?Atul Kalhan, Alan Rees
Current Opinion in Lipidology|November 26, 2009
Therapy and clinical trials: glycaemic control and cardiovascular diseaseMahamood Edavalath, Alan Rees
Pageof 5